158 related articles for article (PubMed ID: 8748841)
1. Invasive meningioma: a tumour with high proliferating and "recurrence" potential.
Suwa T; Kawano N; Oka H; Ito H; Kameya T
Acta Neurochir (Wien); 1995; 136(3-4):127-31. PubMed ID: 8748841
[TBL] [Abstract][Full Text] [Related]
2. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
3. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.
Demirtaş E; Yilmaz F; Ovül I; Oner K
Acta Neurochir (Wien); 1996; 138(12):1456-63. PubMed ID: 9030354
[TBL] [Abstract][Full Text] [Related]
5. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
6. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Neurol Med Chir (Tokyo); 1995 May; 35(5):289-93. PubMed ID: 7623949
[TBL] [Abstract][Full Text] [Related]
7. Invasive meningiomas in relation to high proliferating potential.
Suwa T; Kawano N; Kameya T; Ito H; Oka H; Yada K
Noshuyo Byori; 1993; 10(1):63-7. PubMed ID: 7693228
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
9. Can recurrence of meningiomas be predicted?
Kalala JP; Benoit D; De Ridder L
Anticancer Res; 2004; 24(4):2319-24. PubMed ID: 15330178
[TBL] [Abstract][Full Text] [Related]
10. Predicting recurrence of intracranial meningiomas. A multivariate clinicopathologic model--interim report of the New York University Medical Center Meningioma Project.
Miller DC
Neurosurg Clin N Am; 1994 Apr; 5(2):193-200. PubMed ID: 8032222
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of argyrophilic nucleolar organizer region staining in predicting the behavior of meningiomas.
Ahmadi SA; Samadi N
Ann Saudi Med; 2006; 26(1):38-42. PubMed ID: 16521873
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
13. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma.
Cobb MA; Husain M; Andersen BJ; al-Mefty O
J Neurosurg; 1996 Jan; 84(1):85-90. PubMed ID: 8613841
[TBL] [Abstract][Full Text] [Related]
14. Recurring intracranial meningiomas. Evaluation of some factors predisposing for tumor recurrence.
Böker DK; Meurer H; Gullotta F
J Neurosurg Sci; 1985; 29(1):11-7. PubMed ID: 4067631
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions in meningiomas.
Radhakrishnan VV; Radhakrishnan NS; Rout D; Misna BK
Br J Neurosurg; 1993; 7(4):377-81. PubMed ID: 8216907
[TBL] [Abstract][Full Text] [Related]
16. Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.
Fukui M; Iwaki T; Sawa H; Inoue T; Takeshita I; Kitamura K
Acta Neurochir (Wien); 1986; 81(3-4):135-41. PubMed ID: 3529838
[TBL] [Abstract][Full Text] [Related]
17. Rapidly growing histologically benign meningiomas: cell kinetic and deoxyribonucleic acid ploidy features: report of three cases.
Kudoh C; Sugiura K; Yoshimizu N; Detta A
Neurosurgery; 1995 Nov; 37(5):998-1000; discussion 1000-1. PubMed ID: 8559351
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of nuclear DNA content in human meningiomas: a prospective study.
Meixensberger J; Janka M; Zellner A; Roggendorf W; Roosen K
Acta Neurochir Suppl; 1996; 65():70-2. PubMed ID: 8738500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
